retatrutide needles Delivers Significant Hemoglobin A1C Reduction, Weight Loss in Phase 3 Type 2 Diabetes Trial ESC 2024: Retatrutide improves lipid
Description
Tirzepatide added GIP receptor activation to GLP-1, demonstrating that multi-receptor approaches could enhance weight loss without proportionally increasing side effects
Achieving nearly 30% weight loss with a medication challenges previous assumptions about the upper limits of drug-induced weight reduction and brings us closer to the efficacy seen with bariatric surgery (30-40% weight loss), but without the surgical risks and recovery time
If you are lean with less subcutaneous tissue on the thigh, use a 45-degree angle to avoid reaching the muscle layer
[DOI] [PMC free article] [PubMed] [Google Scholar] Yamamoto H, Lee CE, Marcus JN, Williams TD, Overton JM, Lopez ME, Hollenberg AN, Baggio L, Saper CB, Drucker DJ, et al
Follow the dosing instructions from your provider to select the correct dose
M., Ayoub-Charette, S., Chen, V., Lin, E
